Severe Chilblain Lupus Is Associated with Heterozygous Missense Mutations of Catalytic Amino Acids or their Adjacent Mutations in the Exonuclease Domains of 3′-Repair Exonuclease 1  by Sugiura, Kazumitsu et al.
Severe Chilblain Lupus Is Associated with Heterozygous
Missense Mutations of Catalytic Amino Acids or their
Adjacent Mutations in the Exonuclease Domains of
30-Repair Exonuclease 1
Journal of Investigative Dermatology (2012) 132, 2855–2857; doi:10.1038/jid.2012.210; published online 21 June 2012
TO THE EDITOR
Chilblain lupus (CL) is a subtype of
chronic cutaneous lupus erythemato-
sus. Familial CL (FCL), inherited via an
autosomal dominant trait, has been
described in two families segregating
distinct mutations in the 30-repair
DNA exonuclease 1 (TREX1) (Lee-
Kirsch et al., 2007a; Rice et al., 2007).
TREX1 is a potent 30–50 exonuclease
that degrades single- and double-
stranded DNA (ssDNA and dsDNA) in
mammalian cells. TREX1 belongs to the
exonuclease DEDDh family, whose
members display low levels of se-
quence homology while possessing a
common fold and identical active
site organization termed the ‘‘DEDDh
motif’’(Brucet et al., 2007).
Here we describe a Japanese case of
FCL with the novel missense mutation
p.Pro132Ala in TREX1. We demon-
strate that the mutant TREX1 shows
slightly reduced ssDNA cleavage func-
tion by in vitro exonuclease assays
using recombinant mutant TREX1 pro-
teins. A review of clinical features in
patients with heterozygous missense
mutations that are catalytic residues of
or adjacent to the DEDDh motif in the
three exonuclease domains of TREX1,
including our case, revealed that all the
patients had severe CL.
The patient was a 62-year-old Japanese
woman with painful bluish-red infil-
trates with atrophic branching and
ulcers on the fingers, hands, toes,
cheeks, lips, and nose, which persisted
in all seasons (Figure 1a and b). The
eruptions occurred from 1 year of age.
Five of her relatives from three genera-
tions had similar skin symptoms from
early childhood (Figure 1d). Apart from
the skin findings, physical examination
was unremarkable. She never had any
neurological symptoms. Histological
examination of lesional skin from the
left hand showed typical features of
lupus erythematosus (Figure 1c). La-
boratory investigations revealed the
presence of antinuclear antibodies
showing a homogeneous pattern with
a titer of 1:80. Circulating autoantibo-
dies against dsDNA and ssDNA were
undetectable. Serum IgA and IgG were
slightly elevated. There was no serolo-
gical evidence for viral or bacterial
infections. All other laboratory values,
including complete blood cell count
with differential coagulation, circulat-
ing complement factors, and liver
function tests, as well as urine analysis,
were within normal ranges. On the
basis of the clinical, serological, and
histological findings, as well as family
history, FCL was suspected.
The ethics committee of Nagoya
University approved the studies de-
scribed below. The study was con-
ducted according to the Declaration of
Helsinki Principles. The participants
gave written informed consent. The
coding region of TREX1 was amplified
from genomic DNA from blood by
PCR. Direct sequencing of the patient’s
PCR products revealed that the patient
carried the heterozygous missense
mutation p.Pro132Ala (c.394 C4G) in
TREX1 (Figure 1e), which was not
detected in the 100 control individuals
(data not shown). The proline residue
mutated by p.Pro132Ala is adjacent to
the second aspartic acid residue of the
DEDDh motif, an active catalytic site in
the exonuclease domain of TREX 1
(Figure 2a). This proline residue was
confirmed to be highly conserved in
mammalians (Figure 2b). Thereafter, the
ssDNA exonuclease activities were mea-
sured. Compared with the exonuclease
activities of wild-type TREX1, those of
TREX1 (P132A) were slightly reduced
(Supplemental Figure S1 online).
TREX1 mutations are known to un-
derlie four genetic disorders with dis-
tinctive phenotypes: Aicardi–Goutie`res
syndrome (AGS), retinal vasculopathy
with cerebral leukodystrophy, systemic
lupus erythmatosus (SLE), and FCL
(Crow et al., 2006; Lee-Kirsch et al.,
2007b; Richards et al., 2007). The
majority of TREX1 mutations causing
autosomal recessive AGS are predicted
to be complete loss-of-function muta-
tions. Only three AGS cases caused by
heterozygous TREX1 mutations have
been reported, and the causative TREX1
mutations were p.Asp18Asn, p.As-
p200Asn, and p.Asp200His. It is note-
worthy that all three patients had early-
onset CL (Rice et al., 2007; Haaxma
et al., 2010; Ramantani et al., 2010).
The mutations in TREX1 in SLE
patients were not reported in the
exonuclease domains, except for the
p.Arg128Asp mutation found in an SLE
patient. The patient was suffering from
neuropsychiatric lupus with digital
gangrene (de Vries et al., 2010).
With regard to FCL, only two TREX1
mutations in two families have been
reported. Rice et al. (2007) reported
the TREX1 mutation c.375dupT in an
FCL family with 67% (2 of 3) sympto-
matic penetrance. The mutation
produced p.Asp125fs, which causes
defects in key catalytic domains in the
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exonuclease domains II and III. It is
noteworthy that one member of a family
with FCL with c.375dupT had no CL or
other symptoms even with this mutation.
Therefore, the c.375dupT mutation of
TREX1 does not always cause CL. Lee-
Kirsch et al. (2006, 2007a) reported
another heterozygous missense muta-
tion, p.Asp18Asn, in TREX1 in 13
patients in one large family with FCL. It
is intriguing that p.Asp18Asn was also
detected in an AGS patient showing CL
(Haaxma et al., 2010).
In summary, of all cases having
heterozygous missense mutations in the
three exonuclease domains of TREX1,
we found 18 patients available for
clinical information, including the pre-
sent case, with a total of five missense
mutations, and all the cases had
severe early-onset CL or finger gangrene
(Figure 2c). Of the five, three
were heterozygous missense mutations,
p.Asp18Asn, p.Asp200Asn, and p.As-
p200His, which involve key catalytic
residues of DEDDh motif, asparatic
acids at codon No. 18 and No. 200
directly. The three missense mutations
possess significantly reduced exonu-
clease activity against ssDNA and, in
addition, to inhibit wild-type protein
activity in vitro (Lee-Kirsch et al.,
2007a; Lehtinen et al., 2008). The other
two mutations, p.Arg128His and
p.Pro132Ala, are missense mutations at
conserved amino acids adjacent to the
DEDDh motif. In addition, we speculate
that these mutations have slightly re-
duced TREX1 exonuclease activity, but
inhibit wild-type protein activity by
forming dimers of wild-type and mutant.
We also reviewed all heterozygous
missense mutations of TREX1 that are
outside of the exonuclease domains. A
total of 20 SLE cases with 10 types of
heterozygous missense mutations
were described, but none of these had
CL (Lee-Kirsch et al., 2007b; Namjou
et al., 2011).
In conclusion, it is noteworthy that
heterozygous missense mutations of
DEDDh motif or their adjacent in the
exonuclease catalytic domain of TREX1
always lead to severe CL, without
exception. Further studies are needed
to elucidate the exact mechanisms of
how the defective TREX1 activity results
in the specific CL phenotype.
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Figure 1. Skin manifestations, pathological tissue, family tree, and TREX1 DNA sequence data of the
patient. (a, b) Chilblain lesions on the nose, cheeks, lips, hands, and fingertips of the patient. The patient
provided written informed consent for publication of photographs. (c) Pathological tissue of left hand of
the patient. In the upper dermis, the vessel walls appear dilated, and sparse perivascular lymphocytic
infiltrations are observed. Basement membrane is thickened. Bar¼ 50mm. (d) Family tree of the patient; arrow
denotes the patient. Square represents male member, and circle represents female member; filled symbols
indicate family members with clinical features of familial chilblain lupus. (e) Sequence data of TREX1
in the patient and control; arrow shows heterozygous mutation of 394C4G. Pt., patient; Cont., control.
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Figure 2. Diagram of TREX1, and alignment of DEDDh exonucleases and human heterozygous missense
mutations in the catalytic domain of TREX1. (a) Diagram of TREX1. Exo represents exonuclease-
conserved motifs, PII the polyproline II motif, and TMHD the transmembrane helix domain. Enzymes
from the DEDDh 30–50exonuclease superfamily are characterized by five acidic residues (three aspartates
(D), one glutamate (E), and one histidine (H)). (b) Sequence alignment of Exo II in TREX1. DEDDh motif is
indicated in blue, and P132 is in red. (c) Human heterozygous missense mutation of TREX1 identified in
the Exos. Black indicates mutations identified in AGS cases; blue indicates mutations in AGS and FCL
cases; and purple indicates mutations in neuropsychiatric systemic lupus erythematosus. Red indicates
the present case of familial chilblain lupus. All patients have severe chilblain lupus.
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TO THE EDITOR
Filaggrin (filament-aggregating protein)
is a major structural component of the
cornified envelope, which is crucial for
formation of the stratum corneum (SC)
barrier. It is synthesized as a large
precursor, which is stored in the kerato-
hyalin granules in the granular layer.
Upon cornification, filaggrin units are
generated by proteolysis and released to
promote aggregation of keratin inter-
mediate filaments into macrofibrils (re-
viewed in Brown and McLean, 2012).
During the final cornification steps,
filaggrin is degraded into single amino
acids by several enzymes. These hygro-
scopic amino acids, together with their
derivatives, are the main components of
the natural moisturizing factors (NMFs)
needed for hydration of the SC (Scott
et al., 1982). We have shown that
caspase-14, a unique member of the
caspase protease family, can directly
cleave the filaggrin monomer in vitro
(Hoste et al., 2011). Moreover, caspase-
14-deficient mice accumulate incom-
plete filaggrin breakdown products with-
in the SC, leading to reduced levels of
NMF and lower SC hydration (Hoste
et al., 2011). In addition, transepidermal
water loss is increased in these mice,
which are also sensitized to UVB photo-
damage (Denecker et al., 2007).
An important component of the
NMFs is trans-urocanic acid (trans-
UCA), a product of histidine deimina-
tion by the enzyme histidase. Trans-
UCA acts as a major chromophore in
the skin and is converted by UVB to cis-
UCA, which has immunomodulatory
functions (Gibbs et al., 2008). We
hypothesized that the increase in UVB-
induced photodamage in caspase-14-
deficient mice is the consequence of
lower levels of trans-UCA in the SC of
these mice compared with wild type.
This hypothesis is supported by two
recent findings: (1) knockdown of filag-
grin in a human skin model leads to
Abbreviations: AD, atopic dermatitis; CPD, cyclobutane pyrimidine dimer; filaggrin, filament-aggregating
protein; NMF, natural moisturizing factor; OVA, ovalbumin; SC, stratum corneum;
trans-UCA, trans-urocanic acid
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